Ubs Group Ag Surrozen, Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.44 - $0.89 $2,094 - $4,237	4,761 New	4,761 $2,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.32 $7,490 - $17,655	13,375 Added 713.33%	15,250 $9,000
Q4 2022 Feb 08, 2023	BUY	$0.42 - $2.01 $456 - $2,186	1,088 Added 138.25%	1,875 $1,000
Q3 2022 Nov 10, 2022	BUY	$0.26 - $3.53 $204 - $2,778	787 New	787 $2,000

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $342M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.